The effect of age in the usage of alpha receptor blocker treatment in prostate patients.

Age was considered in the usage of alpha receptor blocker in the treatment of prostate patients. Ninety patients with prostatism were treated with alpha 1 receptor blockers (Doxazocin 4 mg/day) for 8 weeks. Before and after treatment, the patients in two groups according to their age, above and below 60 years, were evaluated using International Prostate Symptom Score (IPSS).

Transitional cell carcinoma of the bladder in patients under 30 years of age.

Transitional cell carcinoma of the bladder is rare in patients younger than 30 years. We report two cases of bladder cancer under the age of 30, regarding clinical picture, treatment and follow-up results.